Form 8-K

0001193125-11-239225.txt : 20110901 0001193125-11-239225.hdr.sgml : 20110901 20110901170944 ACCESSION NUMBER: 0001193125-11-239225 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20110901 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110901 DATE AS OF CHANGE: 20110901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYS Investments, Inc. CENTRAL INDEX KEY: 0001396446 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 204072657 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33740 FILM NUMBER: 111071650 BUSINESS ADDRESS: STREET 1: 437 MADISON AVENUE STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 612-3210 MAIL ADDRESS: STREET 1: 437 MADISON AVENUE STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Cypress Sharpridge Investments, Inc. DATE OF NAME CHANGE: 20070413 8-K 1 d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): September 1, 2011

CYS Investments, Inc.

(Exact name of registrant as specified in its charter)

Maryland

001-33740

20-4072657

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

890 Winter Street, Suite 200

Waltham, Massachusetts 02451

(Address of principal executive offices)

Registrant’s telephone number, including area code: (617) 639-0440

Cypress Sharpridge Investments, Inc.

437 Madison Avenue, 33rd Floor

New York, New York 10022

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02.

DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On September 1, 2011, CYS Investments, Inc. (the “Company”) completed the acquisition of certain assets and entered into agreements to internalize the Company’s management (the “Internalization”). This Form 8-K is being filed to disclose, among other things, the transactions that were completed and the agreements that various parties executed in order to complete the Internalization.

Employment Agreements

In connection with the Internalization, the Company entered into employment agreements with its current Chief Executive Officer and President, Kevin E. Grant, as Chief Executive Officer, President and Chief Investment Officer, its current Chief Financial Officer and Treasurer, Frances R. Spark, as Chief Financial Officer and Treasurer, its current Chief Operating Officer, Richard E. Cleary, as Chief Operating Officer and Assistant Secretary, and its current Secretary, Thomas A. Rosenbloom, as Executive Vice President of Business Development, General Counsel and Secretary.

Mr. Grant’s employment agreement has an initial term of four years beginning on September 1, 2011, and each of the employment agreements for Ms. Spark, Mr. Cleary and Mr. Rosenbloom has an initial term of three years beginning on September 1, 2011. Following the initial term, each employment agreement automatically will extend on an annual basis for one additional year, unless notice not to renew the Employment Agreement is given 90 days prior to the expiration of its term. Each of these executives will receive an annualized base salary for 2011 as follows: Mr. Grant—$750,000; Ms. Spark—$500,000; Mr. Cleary—$450,000; and Mr. Rosenbloom—$450,000. In subsequent years during the term, the base salary under the Employment Agreement will be subject to annual review and adjustment from time to time by the Compensation Committee of the Company’s Board of Directors (the “Board”).

The employment agreements provide that Mr. Grant, Ms. Spark, Mr. Cleary and Mr. Rosenbloom will be eligible to participate in, and be paid a performance bonus under, the incentive compensation plan that was adopted by the Board in connection with the Internalization (the “Bonus Plan”). The Bonus Plan is described in more detail below.

Each employment agreement provides that, upon execution of a release agreement satisfactory to the Company and the executive, each executive will receive severance payments in the event of termination of his or her employment with the Company (including as a result of non-renewal by the Company at the end of the term) other than a termination by the Company for “cause” (as defined in the employment agreements), or by the executive with “good reason” (as defined in the employment agreements). These severance payments include:

•

a multiple of the executive’s average base salary and performance bonus for the three fiscal years preceding the termination date. The multiples are as follows: Mr. Grant—2.5 (2.0 in the case of a termination due to a non-renewal); and Ms. Spark, Mr. Cleary and Mr. Rosenbloom—1.0;

•

a pro-rated bonus for the year of termination based on the target annual bonus; and

•

full vesting of all Company equity awards as of the date of termination.

Each employment agreement also provides that, upon execution of a release agreement satisfactory to the Company and the executive, each executive will receive severance payments in the event the Company terminates his or her employment due to the executive’s disability (as defined in the employment agreements). These severance payments include:

•

a multiple of the executive’s average base salary for the three fiscal years preceding the termination date. The multiples are as follows: Mr. Grant—2.0; and Ms. Spark, Mr. Cleary and Mr. Rosenbloom—0.75;

•

a pro-rated bonus for the year of termination based on the target annual bonus; and

•

full vesting of all Company equity awards as of the date of termination.

A copy of each of the employment agreements is filed as an exhibit herewith and incorporated in this Item 5.02 by reference. The above description is a summary of the employment agreements and is qualified in its entirety by the complete text of the agreements.

Bonus Plan

Effective as of September 1, 2011, the Board approved the Bonus Plan to allow the Company’s employees to earn incentive compensation based on the achievement of financial, strategic and individual goals, while more closely aligning the interests of the Company’s employees and stockholders. Under the Bonus Plan, the Compensation Committee will establish a bonus pool each year with the pool comprised of a quantitative component and a qualitative component. For 2011, the bonus pool will not exceed 1.0% of the average net assets of the Company for the year ended December 31, 2011, unless the Board elects to make awards in excess of this limitation. The quantitative component will be determined for 2011 based on the Company’s return on net assets (calculated in accordance with the terms of the Bonus Plan) exceeding the hurdle rates contained in the Bonus Plan. The Bonus Plan also provides that any bonus awards attributable to returns realized because the Company has exceeded the Board’s pre-determined leverage ratio limit will not be paid to participants in the Bonus Plan. The Compensation Committee will determine the size of the qualitative component based on the size of the quantitative component as set forth in the Bonus Plan. The Compensation Committee will determine the amount of the qualitative component based on a number of factors, including the Company’s and the employee’s management of counterparty relations, leverage and liquidity, investor relations, relative total performance and leadership.

Except as set forth in the Bonus Plan, employees will receive 50% of his or her bonus in cash and 50% in shares of restricted stock that will vest ratably on an annual basis over a five-year period. Mr. Grant will be eligible to receive 35% of the total bonus pool allocation; provided that his maximum bonus award under the Bonus Plan will be 500% of his base salary. Ms. Spark will be eligible to receive 10% of the total bonus pool allocation; provided that her maximum bonus award under the Bonus Plan will be 100% of her base salary. Mr. Cleary and Mr. Rosenbloom each will be eligible to receive 8% of the total bonus pool allocation; provided that the maximum bonus award under the Bonus Plan will be 100% of his respective base salary.

A copy of the Bonus Plan is filed as Exhibit 10.5 and incorporated in this Item 5.02 by reference. The above description is a summary of the Bonus Plan and is qualified in its entirety by the complete text of the Bonus Plan.

Restricted Stock Grant and Accelerated Vesting of Restricted Stock

In connection with the execution of Mr. Grant’s employment agreement, Mr. Grant received 150,000 shares of restricted stock on September 1, 2011 that will vest ratably over a five year vesting period, with one-fifth of the shares vesting on each of the first five anniversary dates of the grant date.

In addition, the Company accelerated the vesting of all of Mr. Grant’s outstanding shares of restricted stock issued prior to September 1, 2011, so that all such shares were vested and non-forfeitable on August 31, 2011, immediately prior to the completion of the Internalization.

ITEM 5.03.

AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR

Effective as of September 1, 2011, the Board of Directors (the “Board”) of the Company approved articles of amendment to the Company’s charter that changed the name of the Company from “Cypress Sharpridge Investments, Inc.” to “CYS Investments, Inc.” No other changes to the Company’s charter were included in the articles of amendment. A copy of the articles of amendment is filed herewith as Exhibit 3.1 and incorporated in this Item 5.03 by reference.

ITEM 8.01.

OTHER EVENTS

Internalization

On September 1, 2011, the Company entered into an asset purchase and sale agreement (the “Agreement”) with Sharpridge Capital Management, L.P. (“Sharpridge”). The Company previously had been managed by Cypress Sharpridge Advisors LLC (the “Manager”) pursuant to a management agreement (the “Management Agreement”). The Manager had entered into sub-advisory agreements with Sharpridge and an affiliate of The Cypress Group, pursuant to which the Manager was provided with all of the resources and assets used to operate the Company’s business and manage the Company’s assets (the “Assets”). In addition, the Company assumed certain contracts of Sharpridge, including Sharpridge’s office lease. As required by the terms of the Agreement, the Company granted a paid-up, royalty-free, worldwide license to Mr. Grant to permit him to use the intellectual property sold by Sharpridge to the Company in the Internalization, subject to the non-competition and confidentiality provisions contained in Mr. Grant’s employment agreement. Pursuant to the terms of the Agreement, the Company acquired the Assets and assumed certain liabilities from Sharpridge for a purchase price of $750,000 in cash at closing. In connection with the completion of the Internalization, the Management Agreement, sub-advisory agreements and other ancillary agreements related thereto were terminated without the payment of any termination fee.

A copy of the Agreement is filed as Exhibit 99.1 and incorporated in this Item 8.01 by reference. The above description is a summary of the Agreement and is qualified in its entirety by the complete text of the Agreement.

A copy of the press release announcing the completion of the Internalization is furnished as Exhibit 99.2 to this report and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. Furthermore, the information in the press release attached as Exhibit 99.2 to this report shall not be deemed to be incorporated by reference in the filings of the registrant under the Securities Act of 1933.

Tax Disclosure

The Company is filing as Exhibit 99.3 (which is incorporated by reference herein) a summary of the material U.S. federal income tax considerations relating to the taxation of the Company as a real estate investment trust for U.S. federal income tax purposes and the ownership and disposition of the capital stock of the Company. The summary contained in Exhibit 99.3 updates and is substantially similar to the prior summaries of the U.S. federal income tax treatment of the Company and its stockholders contained in the Company’s Registration Statements on Form S-3. The summary contained in Exhibit 99.3 replaces and supersedes prior summaries of the U.S. federal income tax treatment of the Company and its stockholders to the extent that they are inconsistent with the summary contained in this Form 8-K.

Forward Looking Statements Disclaimer

This Current Report on Form 8-K contains “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995, including with regard to the anticipated benefits under the employment agreements and the Bonus Plan. Forward-looking statements typically are identified by use of the terms such as “believe,” “expect,” “anticipate,” “estimate,” “plan,” “continue,” “intend,” “should,” “may” or similar expressions. Forward-looking statements are based on the Company’s beliefs, assumptions and expectations of the Company’s future performance, taking into account all information currently available to the Company. The Company cannot assure you that actual results will not vary from the expectations contained in the forward-looking statements. All of the forward-looking statements are subject to numerous possible events, factors and conditions, many of which are beyond the control of the Company and not all of which are known to the Company, including, without limitation, market conditions and those described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2011, each of which has been filed with the Securities and Exchange Commission. All forward-looking statements speak only as of the date on which they are made. New risks and uncertainties arise over time, and it is not possible to predict those events or how they may affect us. Except as required by law, the Company is not obligated to, and does not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

ITEM 9.01.

FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.


Exhibit No.		Description
3.1		Articles of Amendment, effective as of September 1, 2011
8.1		Opinion of Hunton & Williams LLP with respect to tax matters
10.1		Employment Agreement, dated September 1, 2011, between the Company and Kevin E. Grant
10.2		Employment Agreement, dated September 1, 2011, between the Company and Frances R. Spark
10.3		Employment Agreement, dated September 1, 2011, between the Company and Richard E. Cleary
10.4		Employment Agreement, dated September 1, 2011, between the Company and Thomas A. Rosenbloom
10.5		Incentive Compensation Plan
99.1		Asset Purchase and Sale Agreement, dated September 1, 2011, between the Company and Sharpridge
99.2		Press Release, dated September 1, 2011, issued by the Company announcing the completion of the internalization of its management
99.3		Material U.S. Federal Income Tax Considerations

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	CYS INVESTMENTS, INC.

Dated: September 1, 2011	BY:	/s/ FRANCES R. SPARK
		Frances R. Spark Chief Financial Officer and Treasurer

EXHIBIT INDEX


Exhibit Number		Description
3.1		Articles of Amendment, effective as of September 1, 2011
8.1		Opinion of Hunton & Williams LLP with respect to tax matters
10.1		Employment Agreement, dated September 1, 2011, between the Company and Kevin E. Grant
10.2		Employment Agreement, dated September 1, 2011, between the Company and Frances R. Spark
10.3		Employment Agreement, dated September 1, 2011, between the Company and Richard E. Cleary
10.4		Employment Agreement, dated September 1, 2011, between the Company and Thomas A. Rosenbloom
10.5		Incentive Compensation Plan
99.1		Asset Purchase and Sale Agreement, dated September 1, 2011, between the Company and Sharpridge
99.2		Press Release, dated September 1, 2011, issued by the Company announcing the completion of the internalization of its management
99.3		Material U.S. Federal Income Tax Considerations

EX-3.1 2 dex31.htm ARTICLES OF AMENDMENT Articles of Amendment

Exhibit 3.1

CYPRESS SHARPRIDGE INVESTMENTS, INC.

ARTICLES OF AMENDMENT

THIS IS TO CERTIFY THAT:

FIRST: The charter (the “Charter”) of Cypress Sharpridge Investments, Inc., a Maryland corporation (the “Company”), is hereby amended to provide that, at the Effective Time (as defined below), the name of the Company shall be changed from “Cypress Sharpridge Investments, Inc.” to “CYS Investments, Inc.”

SECOND: The amendment to the Charter of the Company as set forth above has been duly approved by a majority of the Board of Directors of the Company as required by the Maryland General Corporation Law and the Company’s Charter.

THIRD: These Articles of Amendment shall be effective at 12:01 a.m., Eastern Time, on September 1, 2011 (the “Effective Time”).

FOURTH: The undersigned Chief Executive Officer and President acknowledges these Articles of Amendment to be the corporate act of the Company and as to all matters or facts required to be verified under oath, the undersigned Chief Executive Officer and President acknowledges that to the best of his knowledge, information and belief, these matters and facts are true in all material respects and that this statement is made under the penalties for perjury.

[SIGNATURE PAGE FOLLOWS]

IN WITNESS WHEREOF, the Company has caused these Articles of Amendment to be executed in its name and on its behalf by its Chief Executive Officer and President and attested to by its Secretary on this 31st day of August, 2011.


ATTEST:		CYPRESS SHARPRIDGE INVESTMENTS, INC.

By:	/s/ Thomas A. Rosenbloom	By:	/s/ Kevin E. Grant
Name:	Thomas A. Rosenbloom	Name:	Kevin E. Grant
Title:	Secretary	Title:	Chief Executive Officer and President

EX-8.1 3 dex81.htm OPINION OF HUNTON & WILLIAMS Opinion of Hunton & Williams

Exhibit 8.1

HUNTON & WILLIAMS LLP

RIVERFRONT PLAZA, EAST TOWER

951 EAST BYRD STREET

RICHMOND, VIRGINIA 23219-4074

TEL 804 • 788 • 8200

FAX 804 • 788 • 8218

September 1, 2011

CYS Investments, Inc.

890 Winter Street, Suite 200

Waltham, Massachusetts 02451

CYS Investments, Inc.

Qualification as

Real Estate Investment Trust

Ladies and Gentlemen:

We have acted as special tax counsel to CYS Investments, Inc., a Maryland corporation (the “Company”), in connection with the preparation of a Form 8-K (the “Form 8-K”) filed with the Securities and Exchange Commission on the date hereof. You have asked for our opinion regarding certain U.S. federal income tax matters.

The Company owns interests in residential mortgage-backed securities and subordinated tranches of asset-backed securities, including collateralized debt obligations.

In giving this opinion letter, we have examined the following:

1.	the Company’s Articles of Amendment and Restatement;

2.	the Form 8-K;

3.	the TRS elections for Sharpridge TRS, Inc. (dissolved on December 31, 2009) and CS Alternatives TRS, Inc. (dissolved on February 19, 2009); and

4.	such other documents as we have deemed necessary or appropriate for purposes of this opinion.

In connection with the opinions rendered below, we have assumed, with your consent, that:

1. each of the documents referred to above has been duly authorized, executed, and delivered; is authentic, if an original, or is accurate, if a copy; and has not been amended;

ATLANTA AUSTIN BANGKOK BEIJING BRUSSELS CHARLOTTE DALLAS HOUSTON LONDON LOS ANGELES

McLEAN MIAMI NEW YORK NORFOLK RALEIGH RICHMOND SAN FRANCISCO WASHINGTON

www.hunton.com

CYS Investments, Inc.

September 1, 2011

Page 2

2. during its taxable year ending December 31, 2011, and future taxable years, the Company will operate in a manner that will make the representations contained in a certificate, dated the date hereof and executed by duly appointed officers of the Company (the “Officers’ Certificate”), true for such years, without regard to any qualifications as to knowledge or belief;

3. the Company will not make any amendments to its organizational documents after the date of this opinion that would affect the Company’s qualification as a real estate investment trust (a “REIT”) for any taxable year; and

4. no action will be taken by the Company after the date hereof that would have the effect of altering the facts upon which the opinions set forth below are based.

In connection with the opinions rendered below, we also have relied upon the correctness, without regard to any qualification as to knowledge or belief, of the factual representations and covenants contained in the Officers’ Certificate and the factual matters discussed in the Prospectus that relate to the Company’s status as a REIT. We are not aware of any facts that are inconsistent with the representations contained in the Officers’ Certificate. Furthermore, where the factual representations in the Officers’ Certificate involve terms defined in the Internal Revenue Code of 1986, as amended (the “Code”), the Treasury regulations thereunder (the “Regulations”), published rulings of the Internal Revenue Service (the “Service”), or other relevant authority, we have reviewed with the individuals making such representations the relevant provisions of the Code, the applicable Regulations, the published rulings of the Service, and other relevant authority.

Based on the documents and assumptions set forth above, the representations and covenants set forth in the Officers’ Certificate, and the factual matters discussed in the Form 8-K under the caption “Material U.S. Federal Income Tax Considerations” (which are incorporated herein by reference), we are of the opinion that:

(a) the Company qualified to be taxed as a REIT pursuant to sections 856 through 860 of the Code for its taxable years ended December 31, 2006 through December 31, 2010, and the Company’s organization and current and proposed method of operation will enable it to continue to qualify as a REIT under the Code for its taxable year ending December 31, 2011 and thereafter; and

(b) the descriptions of the law and the legal conclusions contained in the Form 8-K under the caption “Material U.S. Federal Income Tax Considerations” are correct in all material respects.

CYS Investments, Inc.

September 1, 2011

Page 3

We will not review on a continuing basis the Company’s compliance with the documents or assumptions set forth above, or the representations set forth in the Officers’ Certificate. Accordingly, no assurance can be given that the actual results of the Company’s operations for any given taxable year will satisfy the requirements for qualification and taxation as a REIT. Although we have made such inquiries and performed such investigations as we have deemed necessary to fulfill our professional responsibilities as counsel, we have not undertaken an independent investigation of all the facts referred to in this opinion letter or the Officers’ Certificate.

The foregoing opinions are based on current provisions of the Code and the Regulations, published administrative interpretations thereof, and published court decisions. The Service has not issued Regulations or administrative interpretations with respect to various provisions of the Code relating to REIT qualification. No assurance can be given that the law will not change in a way that will prevent the Company from qualifying as a REIT.

The foregoing opinions are limited to the U.S. federal income tax matters addressed herein, and no other opinions are rendered with respect to other U.S. federal tax matters or to any issues arising under the tax laws of any other country, or any state or locality. We undertake no obligation to update the opinions expressed herein after the date of this letter. This opinion letter is solely for the information and use of the addressees, and it speaks only as of the date hereof. Except as provided in the next paragraph, this opinion letter may not be distributed, quoted in whole or in part or otherwise reproduced in any document, or filed with any governmental agency without our express written consent.

We hereby consent to the filing of this opinion as an exhibit to the Form 8-K. We also consent to the references to Hunton & Williams LLP under the captions “Material U.S. Federal Income Tax Considerations” in the Form 8-K. In giving this consent, we do not admit that we are in the category of persons whose consent is required by Section 7 of the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder by the Securities and Exchange Commission.

Very truly yours,

/s/ Hunton & Williams LLP

EX-10.1 4 dex101.htm EMPLOYMENT AGREEMENT / KEVIN E. GRANT Employment Agreement / Kevin E. Grant

Exhibit 10.1

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on September 1, 2011, and will become effective on September 1, 2011 (the “Effective Date”), by and between Kevin E. Grant (the “Executive”) and CYS Investments, Inc., a Maryland corporation (the “Company”).

WHEREAS, the Company desires to retain certain employees, including the Executive, in connection with the transactions (the “Internalization”) described in that certain Asset Purchase and Sale Agreement by and between the Company and Sharpridge Capital Management, L.P., dated as of September 1, 2011 (the “Asset Purchase Agreement”); and

WHEREAS, the Company desires to establish its right to the continued services of the Executive beginning on the Effective Date, in the capacity described below, on the terms and conditions and subject to the rights of termination hereinafter set forth, and the Executive is willing to accept such employment in such capacity and on such terms and conditions.

NOW, THEREFORE, in consideration of the mutual promises and agreements herein made and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties agree as follows:

1. Definitions. The following capitalized terms used in this Agreement shall have the respective meanings assigned to them below:

1.1 “Act” means the Securities Exchange Act of 1934, as amended, or any successor thereto.

1.2 “Affiliate” or “Affiliated Entity” means any entity that controls, is controlled by, or is under common control with the Company;

1.3 “Board” means the Board of Directors of the Company.

1.4 “Beneficial Owner” means a “beneficial owner” as such term is used for purposes of Sections 13(d) and 14(d) of the Act (or any successor section thereto).

1.5 “Business Day” means Monday through Friday of each week, except a legal holiday recognized as such by the U.S. Government or any day on which banking institutions in the State of New York are authorized or obligated by law to close.

1.6 “Change of Control” means the occurrence of any one of the following events:

a. stockholder approval of the complete liquidation or dissolution of the Company; or

b. the sale or disposition, in one or a series of related transactions, of all or substantially all of the assets of the Company to any Person or Group; or

c. any Person or Group is or becomes the Beneficial Owner, directly or indirectly, of more than 50% of the voting shares of the Company; or

d. a merger, consolidation or statutory share exchange where the Company’s stockholders immediately prior to such event hold less than 50% of the voting power of the surviving or resulting entity; or

e. during any period of two (2) consecutive years, individuals who, as of the Effective Date, constitute the Board (the “Incumbent Directors”) cease for any reason, including, without limitation, as a result of a tender offer, proxy contest, merger or similar transaction, to constitute at least a majority of the Board, provided that any person becoming a member of the Board subsequent to the Effective Date whose election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors shall, for purposes of this Agreement, be considered an Incumbent Director; or

f. the Board adopts a resolution to the effect that, in its judgment, as a consequence of any transaction or event, or a series thereof, a Change of Control has effectively occurred.

If a Change of Control constitutes a payment event with respect to any benefit or payment that provides for the deferral of compensation that is subject to Section 409A of the Code, no payment will be made of that benefit or payment on account of a Change of Control unless the event or transaction that constitutes a Change of Control also constitutes a “change in control event” under Treasury Regulation Section 1.409A-3(i)(5).

1.7 “Code” shall mean the Internal Revenue Code of 1986, as amended.

1.8 “Compensation Committee” shall mean the Compensation Committee of the Board.

1.9 “Confidential Information” means information, knowledge or data disclosed to or known by Executive as a consequence of or through his employment with the Company that relates to any aspect of the Company or its business and assets. “Confidential Information” includes, but is not limited to, any and all confidential information (whether recorded in documentary form or by electronic or other means) relating to the Company’s assets, business methods, investment strategies, hedging strategies, liability management strategies, corporate plans, business plans, strategic plans, employee information (including compensation, qualifications, and utilization), management systems, finances, and existing or developing business opportunities. Confidential Information also includes any other information in respect of which the Company owes an obligation of confidentiality to any third party, knowledge of which the Executive acquired at any time during his employment by the Company and which is not readily ascertainable to persons not connected with the Company, either at all or without significant expenditure of labor, skill or money.

1.10 “Copyright Works” are materials for which copyright protection may be obtained including, but not limited to literary works (including all written material), computer programs, artistic and graphic works (including designs, graphs, drawings, blueprints, and other works), recordings, models, photographs, slides, motion pictures, and audio-visual works, regardless of the form or manner in which documented or recorded.

1.11 “Good Reason” shall mean the occurrence of one or more of the following without the Executive’s written consent: (i) the failure of the Company to pay any amounts due under this Agreement in a timely manner, (ii) a material diminution in the Executive’s duties, authorities or responsibilities; provided, however, that the removal by the Board of the titles of Chairman of the Board, Chief Investment Officer and President from the Executive shall not be deemed “Good Reason” for purposes of this Section 1.11 so long as the Executive retains the title of Chief Executive Officer of the Company, (iii) a reduction of the Executive’s Base Salary (defined below) below $750,000, (iv) the relocation of the Executive’s principal place of employment more than 50 miles from Waltham, Massachusetts, except for a relocation of the Executive’s principal place of employment that is approved by a majority of the independent directors after making a determination that such relocation is in the best interests of the Company, (v) a

material breach of this Agreement by the Company (other than those items set forth in items (i), (ii) or (iii) above), (vi) a failure to nominate the Executive as a member of the Board or (vii) the failure of the Company to obtain the assumption in writing of its obligations to perform this Agreement by any successor to the Company following a Change of Control, if any. The Executive’s termination of employment shall not be on account of Good Reason unless the Executive gives the Company written notice within 90 days of the initial existence of the grounds that the Executive asserts constitute Good Reason, the Company has not cured such grounds within 30 days after the Executive’s notice and the Executive terminates employment within 90 days after the Executive’s notice.

1.12 “Group” shall mean a “group” as such term is used in Sections 13(d) and 14(d) of the Act (or any successor section thereto), acting in concert.

1.13 “Lead Independent Director” means the independent director who has been designated by the Board to serve as the lead independent director of the Company.

1.14 “Person” shall mean a “person” as such term is used for purposes of Sections 13(d) and 14(d) of the Act (or any successor section thereto).

2. Employment as Chairman, Chief Executive Officer, President, and Chief Investment Officer of the Company. The Company hereby currently employs and engages the Executive as Chairman, Chief Executive Officer, President, and Chief Investment Officer of the Company, and the Executive does hereby accept and agree to such employment and engagement. The Executive’s duties as Chairman, Chief Executive Officer, President, and Chief Investment Officer shall be such duties typically required of a chairman, chief executive officer, president, and chief investment officer, and as shall from time to time be agreed upon by the Executive and the Board. The Executive shall report solely and directly to the Board. Except for periods of Disability (as defined below), during the Term, the Executive shall devote substantially all of his business time and attention to perform his duties under this Agreement. The Executive may undertake business activities outside of the duties under this Agreement; provided, however, that (i) such activities do not prevent the Executive from devoting substantially all of his business time and attention to perform his duties under this Agreement and (ii) such activities are first approved by the Board.

3. Term of Agreement.

3.1 Effective Date. The initial term (the “Initial Term”) of this Agreement shall commence as of the Effective Date and shall continue through the fourth anniversary of the Effective Date. From and after such fourth anniversary and upon each anniversary thereafter, the Initial Term shall automatically be extended for successive one-year periods (each such successive one-year period, together with the Initial Term, being the “Term”) unless, not later than 90 days prior to such fourth anniversary or any subsequent anniversary, as applicable, either party shall have given written notice to the other that it does not wish to extend the Term of this Agreement.

3.2 Contingent upon the Asset Purchase Agreement. Notwithstanding anything in this Agreement to the contrary, this Agreement shall become effective as of the Effective Date, and then if and only if the Closing as defined in and contemplated by the Asset Purchase Agreement is actually consummated. In the event that such Closing does not occur, this Agreement shall be terminated, null and void AB INITIO.

4. Compensation.

4.1 Base Salary. The Company shall pay the Executive, and the Executive agrees to accept from the Company, in payment for his services to the Company, a base salary equal to a per annum amount of $750,000 (the “Base Salary”), payable in equal monthly installments in accordance with the Company’s payroll practices. The Base Salary may be adjusted at any time by the Compensation Committee. The Base Salary as adjusted shall be deemed to be the Base Salary for all purposes under this Agreement.

4.2 Performance Bonus.

a. The Executive shall be eligible to participate in, and be paid a performance bonus (the “Performance Bonus”) in accordance with the terms of an incentive compensation plan approved by the Compensation Committee for the Company’s Executives and other eligible employees (the “Incentive Compensation Plan”) each year during the Term.

b. The amount of the benefit that may be earned by the Executive under the Incentive Compensation Plan, the form of Performance Bonus awards made to the Executive and the timing of the payment of such Performance Bonus awards shall each be determined in accordance with the terms of the Incentive Compensation Plan, with such terms to be set annually by the Compensation Committee.

4.3 Retention Restricted Stock Award. Effective as of the Effective Date, and upon execution of this Agreement, the Company shall execute and deliver to the Executive a Restricted Stock Award Agreement (“RSA”) substantially in the form attached hereto as Exhibit A, pursuant to which the Executive shall be granted 150,000 restricted shares of the Company’s common stock, $0.01 par value per share, that will vest on an equal pro rata basis each year for a five year period.

4.4 Annual Review; Discretion to Adjust Compensation. The Compensation Committee shall at least once each fiscal year review the Executive’s compensation package to determine if the package should be adjusted in order for it to continue to meet the Company’s compensation objectives. If the Compensation Committee determines that the Executive’s compensation package should be adjusted pursuant to this Section 4.4, then the Compensation Committee shall recommend such adjustment to the Board. The Executive’s compensation package shall only be adjusted pursuant to this Section 4.4 if approved by the Board. Nothing in this Agreement shall be interpreted to imply that this Agreement guarantees that the Executive’s compensation package will be increased. In addition, nothing in this Agreement shall preclude the Board from adjusting, or the Board and the Compensation Committee from considering adjusting, the Executive’s compensation during the Term of this Agreement. The Base Salary as adjusted shall be the Base Salary for all purposes of this Agreement.

5. Fringe Benefits. The Executive shall be entitled to participate in any benefit programs adopted from time to time by the Company for the benefit of the Company’s executives and/or the Company’s employees generally, and the Executive shall be entitled to receive such other fringe benefits as may be granted to him from time to time by the Compensation Committee.

5.1 Benefit Plans. The Executive shall be entitled to participate in any benefit plans relating to stock options, stock purchases, awards, pension, thrift, profit sharing, life insurance, medical coverage, education, or other retirement or employee benefits available to other senior executive employees of the Company, subject to any restrictions (including waiting periods) specified in such plans.

5.2 Vacation and ESG Paid Time Off. The Executive shall be entitled to such number of weeks of paid vacation per calendar year, including time off to undertake and participate in activities that are charitable or philanthropic in nature in accordance with the Company’s applicable policies regarding environmental, social responsibility and corporate governance, as determined by the Board after review of industry standards, but shall in no event be entitled to fewer than six (6) weeks of paid vacation per calendar year.

6. Business Expenses. The Company shall reimburse the Executive for any and all necessary, customary and usual expenses incurred by Executive on behalf of the Company in accordance with Company policies.

7. Termination of Executive’s Employment.

7.1 Death. If the Executive dies while employed by the Company, his employment shall immediately terminate. The Company’s obligation to pay the Executive’s Base Salary shall cease as of the date of Executive’s death, except that any earned but unpaid Base Salary and Performance Bonus for any performance period that ended before the Executive’s death shall be paid to the Executive’s estate as soon as practicable after his death. In addition, the Executive’s estate shall receive the Performance Bonus for the year of the Executive’s death on a pro-rated basis and the Performance Bonus, if any, shall be paid to the Executive’s estate at the same time and in the same manner as such Performance Bonus would have been paid to the Executive had the Executive’s employment not been terminated by reason of death.

7.2 Disability. If, as a result of the Executive’s incapacity due to physical or mental illness (“Disability”), Executive shall have been absent from the full-time performance of his duties with the Company for six (6) consecutive months, and, within 30 days after written notice is provided to him by the Company, the Executive shall not have returned to the full-time performance of his duties, the Executive’s employment under this Agreement may be terminated by the Company due to the Executive’s Disability. With respect to the period beginning when the Executive is first absent from the full-time performance of his duties with the Company due to Disability and ending upon the later of (i) the date he is terminated from employment in accordance with the foregoing sentence, or (ii) the date he begins receiving long-term disability payments under the Company’s long term disability plan (“Salary Continuation Period”), the Company shall continue to pay the Executive his Base Salary at the rate in effect at the commencement of such period of Disability. Upon a termination of the Executive’s employment by reason of Disability, the Company shall pay to the Executive the severance detailed in Section 8.2 below.

Cause; and (2) if such asserted breach is capable of cure or remedy, a period of 60 days from and after the giving of the notice described in (1) shall have elapsed without the Executive having effectively cured or remedied such asserted breach to the reasonable satisfaction of the Board during such 60-day period, unless such asserted breach is of the type that cannot be cured or remedied within 60 days, in which case the period for remedy or cure shall be extended for a reasonable time (not to exceed an additional 30 days), provided the Executive has made and continues to make a diligent effort to effect such remedy or cure. In the case of clause (iv) above, the Executive’s employment under this Agreement may be terminated immediately without any advance written notice. Upon a determination that grounds exist for a termination for Cause by the Board and that the asserted breach cannot be cured, or immediately in the case of clause (iv) above, the Company’s obligation to pay the Executive’s Base Salary, any Performance Bonus and benefits shall immediately cease, except to the extent any Base Salary or Performance Bonus for a performance period that ended before such date and has been earned but has not yet been paid. Additionally, equity awards granted to the Executive which have not yet vested as of the termination date of Executive’s employment with the Company shall be forfeited.

7.4 Termination without Cause. The Company may at any time during the Term of this Agreement terminate the Executive’s employment without Cause by giving the Executive notice in writing not less than 30 days in advance of such termination. In addition, if the Company chooses not to renew this Agreement at any time pursuant to Section 3.1 hereto and the Executive remains employed by the Company until the end of the Term, then such non-renewal shall be deemed a termination without Cause under this Section 7.4. Except as provided in this Agreement, the Executive shall have no further obligations to the Company after the effective date of any termination without Cause, as set forth in the notice. In the event of a termination of the Executive’s employment under this Section 7.4, the Company will pay to the Executive the severance detailed in Section 8.1 below.

7.5 Termination by the Executive. The Executive may at any time during the Term of this Agreement terminate his employment hereunder without Good Reason by giving the Company notice in writing not less 90 days in advance of such termination. Except as set forth in Section 9 of this Agreement, the Executive shall have no further obligations to the Company after the effective date of his termination, as set forth in the notice. In the event of a termination by the Executive under this Section 7.5, the Company will only pay any unpaid Base Salary that was earned but had not yet been paid prior to the termination date of Executive’s employment with the Company. Additionally, equity awards granted to the Executive which have not yet vested as of the termination date of Executive’s employment with the Company shall be forfeited.

7.6 Termination by the Executive for Good Reason. The Executive at any time may terminate his employment for Good Reason. If the Executive terminates his employment for Good Reason, the notice period in Section 7.5 above shall not apply and the Company will pay to the Executive the severance detailed in Section 8.1 below.

8. Termination Payments.

8.1 Compensation upon Termination by the Company other than for Cause or upon Termination by the Executive for Good Reason or upon a Change in Control. If the Executive’s employment shall be terminated by (i) the Company, or its successor, (A) other than for Cause or (B) other than for Cause within 24 months after a Change of Control, or (ii) the Executive (A) for Good Reason at any time or (B) for Good Reason within 12 months following a Change in Control, then the Company, or its successor, shall pay, and the Executive shall be entitled to receive, the following amounts and benefits:

a. Payment of Unpaid Base Salary and Performance Bonus. The Company shall pay the Executive, in a single cash payment, (i) any unpaid Base Salary, (ii) any Performance Bonus that was earned for performance periods that ended prior to the termination date of Executive’s employment with the Company and has not been paid and (iii) the pro rata Performance Bonus for the year of the Executive’s termination of employment with the Company.

b. Severance Payment. The Company shall pay the Executive an amount (the “Severance Amount”) equal to two and one-half (2.5) times the average of the Executive’s (i) Base Salary plus (ii) the Performance Bonus earned during the shorter of (A) the three (3) fiscal years immediately preceding the year in which the termination of the Executive’s employment occurs or (B) the period of time beginning on the date of this Agreement and ending on the termination date of Executive’s employment with the Company; provided, however, that if the Executive’s employment is terminated due to the Company’s failure to renew this Agreement pursuant to Section 3.1 hereto, then the Company shall pay the Executive an amount equal to two (2) times (instead of two and one-half (2.5) times) the average of the Executive’s (i) Base Salary plus (ii) Performance Bonus during the three fiscal years immediately preceding the year in which the termination of the Executive’s employment occurs. Fifty percent (50%) of the Severance Amount shall be paid by the later of (i) 30 days after the date the Executive terminates for Good Reason or is terminated by the Company for any reason other than Cause or (ii) five (5) Business Days after the effectiveness of the Executive’s Release (defined below), and the remaining fifty percent (50%) of the Severance Amount shall be paid on or before March 15 of the year following the year in which the Executive terminates for Good Reason or is terminated by the Company for any reason other than Cause or, if sooner, in three (3) equal monthly installments beginning on the first business day of the month following the month of such termination.

c. Immediate Vesting of Stock Options. The Company shall take all appropriate action such that all stock options on the Company’s stock owned by the Executive as of the termination date of Executive’s employment with the Company, and which have not vested prior to the termination date of the Executive’s employment with the Company shall immediately vest. The provisions of this Section 8.1(c) shall constitute an amendment to any existing stock option agreements (including award certificates) of the Company as of the termination date of Executive’s employment with the Company.

d. Immediate Vesting of Restricted Stock Grants. The Company shall take all appropriate action such that all shares subject to forfeiture under any RSAs shall become fully vested, and no longer subject to forfeiture in accordance with the terms of such RSAs. The provisions of this Section 8.1(d) shall constitute an amendment to any existing RSAs by and between the Company and the Executive as of the termination date of Executive’s employment with the Company.

reduction were not made. The payments or benefits shall be reduced by first reducing payment or benefits that are not subject to Section 409A of the Code and thereafter, if necessary, reducing payments or benefits that are subject to Section 409A of the Code in the manner and order determined by the Company. The determination of whether the payments shall be reduced as provided in this Section 8(e) and the amount of such reduction shall be made at the Company’s expense by a public accounting firm retained by the Company at the time the calculation is to be performed, or one selected by the Company from among the four (4) largest public accounting firms in the United States (the “Accounting Firm”). The Accounting Firm shall provide its determination, together with detailed supporting calculations and documentation to the Company and the Executive within 20 Business Days of the payment of the initial installment of the Severance Amount. The Executive may review these calculations for a period of 20 days and may retain another accounting firm (at his own expense) for such review and submit objections during such 20-day review period.

f. Continuation of Medical Benefits. The Company shall reimburse the Executive for the amount of premiums paid by the Executive to continue coverage for the Executive and his eligible dependents under the Company’s health plan during the period that the Executive and his eligible dependents are eligible to participate in the Company’s health plan under the terms of the plan and the insurance policy that insures the plan’s benefits, not to exceed 24 months after termination. If the Executive and his eligible dependents are unable to continue participation in the Company’s health plan for at least 24 months after termination, the Company shall reimburse the Executive for the amount of premiums paid by the Executive to continue coverage for the Executive and his eligible dependents under COBRA or any similar State law for the period that such continuation coverage is required.

g. General Release. The obligations of the Company to make any payments to Executive required under Section 8.1 hereof shall be conditioned on the execution and delivery by the Company and the Executive of, and the effectiveness of, a general mutual release of claims in form and substance reasonably satisfactory to the Company and the Executive.

8.2 Compensation upon Termination by the Company for Disability. If the Executive’s employment shall be terminated by the Company for Disability, then the Company shall pay, and the Executive shall be entitled to receive, the following amounts and benefits in addition to those amounts set forth in Section 7.2:

a. Performance Bonus. The Company shall pay to the Executive (i) the unpaid Performance Bonus for any performance period that ended before the termination date of the Executive’s employment with the Company and (ii) the pro rata Performance Bonus for the year of the Executive’s termination of employment with the Company. The Performance Bonus shall be paid to the Executive at the same time and in the same manner as such Performance Bonus would have been paid had the Executive not been terminated by reason of Disability.

b. Severance Amount. The Company shall pay the Executive an amount (the “Disability Severance Amount”) equal to two (2) times the average amount of the Executive’s combined Base Salary during the shorter of (A) three (3) fiscal years immediately preceding the year in which the termination of the Executive’s employment occurs or (B) the period of time beginning on the date of this Agreement and ending on the termination date of Executive’s employment with the Company. The Disability Severance Amount shall be payable in 24 equal monthly installments, commencing with the month immediately following the termination of the Executive’s employment by reason of Disability.

c. Immediate Vesting of Stock Options. The Company shall take all appropriate action such that all stock options on the Company’s stock owned by the Executive as of the termination date of Executive’s employment with the Company, and which have not vested prior to the termination date of the Executive’s employment with the Company shall immediately vest. The provisions of this Section 8.3(c) shall constitute an amendment to any existing stock option agreements (including award certificates) of the Company as of the termination date of Executive’s employment with the Company.

d. Immediate Vesting of Restricted Stock Grants. The Company shall take all appropriate action to such that all shares subject to forfeiture under any RSAs shall become fully vested, and no longer subject to forfeiture in accordance with the terms of such RSAs. The provisions of this Section 8.3(d) shall constitute an amendment to any existing RSAs by and between the Company and the Executive as of the termination date of Executive’s employment with the Company.

e. Continuation of Medical Benefits. The Company shall reimburse the Executive for the amount of premiums paid by the Executive to continue coverage for the Executive and his eligible dependents under the Company’s health plan during the period that the Executive and his eligible dependents are eligible to participate in the Company’s health plan under the terms of the plan and the insurance policy that insures the plan’s benefits, not to exceed 24 months after termination. If the Executive and his eligible dependents are unable to continue participation in the Company’s health plan for at least 24 months after termination, the Company shall reimburse the Executive for the amount of premiums paid by the Executive to continue coverage for the Executive and his eligible dependents under COBRA or any similar State law for the period that such continuation coverage is required.

f. General Release. The obligations of the Company to make any payments to Executive required under Section 8.2 hereof shall be conditioned on the execution and delivery by the Company and the Executive of, and the effectiveness of, a general mutual release of claims in form and substance reasonably satisfactory to the Company and the Executive.

9. Noncompetition, Confidentiality and Non-Dispargement Provisions.

9.1 Noncompetition. The Executive agrees that during the Term of employment under this Agreement prior to any termination of his employment hereunder and, in the event the Executive’s employment shall be terminated by the Company other than for Cause or by the Executive for Good Reason, then for a period of two (2) years following such termination, the Executive will not, directly or indirectly, without the prior written consent of the Company, manage, operate, join, control, participate in, as an officer, employee or otherwise, of any real estate investment trust or other investment vehicle whose business strategy is based on or who engages primarily in the trading, sales or management of residential mortgage-backed securities (the “Business”) in any geographical region in which the Company engages in the Business (a “Competitor”). It is further expressly agreed that the Company will or would suffer irreparable injury in violation of the preceding sentence of this Agreement and that the Company would by reason of such competition be entitled to seek injunctive relief in a court of appropriate jurisdiction, and the Executive further consents and stipulates to the entry of such injunctive relief in such a court prohibiting the Executive from competing with the Company or any subsidiary or affiliate of the Company, in the Business set forth above, in violation of this Agreement.

9.2 Access to Confidential Information and Non-Disclosure Agreement. Upon execution of this Agreement, the Executive will be provided with and will have access to certain Confidential Information. The Executive further agrees that Executive will not, except as the Company may otherwise consent or direct in writing or as may otherwise be required by law or legal process, reveal or disclose, sell, use, lecture upon, publish or otherwise disclose to any third party any Confidential Information, or authorize anyone else to do these things at any time either during or subsequent to his employment with the Company. This Section shall continue in full force and effect after termination of the Executive’s employment for any reason. The Executive’s obligations under this Section 9.2 of this Agreement with respect to any specific Confidential Information shall cease when that specific portion of the Confidential Information becomes publicly known, other than as a result of disclosure by the Executive or any representatives of the Executive in violation of this Agreement, in its entirety and without combining portions of such information obtained separately. It is understood that such Confidential Information includes matters that the Executive conceives or develops, as well as matters the Executive learns from other employees of the Executive. The Executive agrees that he will immediately notify the Company if he receives a subpoena, order from a court or administrative agency or other legal process that seeks to require disclosure of Confidential Information. The nondisclosure obligation set forth in this Section 9.2 is in addition to any fiduciary duties of the Executive to maintain the confidentiality of the Confidential Information and, to the extent not otherwise provided herein, the trade secrets of the Company.

9.3 Work Product. The Executive acknowledges that all ideas, discoveries, programs, systems, methods, techniques, formulas, concepts, works of authorship, interfaces, protocols, databases, creations, artwork, articles, programming, processes, designs, inventions or improvements thereof, whether or not capable of being protected by patent, copyright, trade secret or other intellectual property right (the “Work Product”), conceived by the Executive while employed by, serving as an officer of, or consulting with the Company, or any Affiliate, whether formally or informally, compensated or uncompensated, or whether during regular working hours, or while the Executive is an officer or director of the Company, or any Affiliate, provided such Work Product is related in some manner to the business (present and/or contemplated) of the Company, or any Affiliate, shall be owned and belong exclusively to the Company, or any Affiliate, as the case may be, and that the Executive shall have no personal interest in or right to use the Work Product. The Executive shall, unless the Executive otherwise agrees in writing, and without additional compensation: (i) promptly disclose to the Company all Work Product, and business opportunities related to the present and/or contemplated business of the Company, or any Affiliate (“Business Opportunities”); (ii) assign to the Company, and comply with all reasonable instructions of the Company regarding assigning, upon request, the entire rights to all Work Product and Business Opportunities; (iii) give an affidavit and live testimony (as may be necessary or desirable in the sole and absolute discretion of the Company) in support of his inventorship or creation in any appropriate case; and (iv) execute such other documents and take such other action as may be required to protect the rights of the Company, or any Affiliate in any such Work Product and Business Opportunities, including without limitation, such patent, trademark and copyright applications, as may be necessary or desirable in the sole and absolute discretion of the Company to obtain, maintain, protect or vest in the Company, or any Affiliate the entire right, title and interest in and to the Work Product and Business Opportunities. The Executive agrees that all Work Product, all derivatives thereof, and the Executive’s contributions thereto shall be considered “works made for hire” as contemplated in the U.S. Copyright Act, and shall automatically be owned by the Company, or and/or any applicable Affiliated Entity. If any portion of the Work Product is not ruled to be a “work made for hire,” the Executive hereby assigns and transfers to the Company, or its successors and assigns, absolutely and forever all right, title and interest in and to such Work Product, including, without limitation, the right to use same in any and all versions of the Work Product and in any other works in any media published or licensed by the Company, or any Affiliate and the right to recover for past or future infringements thereof. This provision shall not apply to Work Product for which no equipment, supplies, facility or Confidential Information was used and which was developed entirely on the Executive’s own time, and (a) which does not relate to the business of the Company, or (b) which does not result from any work performed by Executive for the Company.

9.4 Return of Property. The Executive acknowledges that all Work Product and other writings, records and other documents and things comprising, containing, describing, discussing, explaining or evidencing any Confidential Information and all letters, notes, notebooks, computer data and programs, lists, books, records of any kind and any other written or other materials relating to Work Product and/or Confidential Information and all other property belonging to the Company in the Executive’s custody or possession that has been obtained or prepared in the course of the Executive’s employment with the Company shall be the exclusive property of the Company, shall not be copied and/or removed from the premises of the Company, except in pursuit of the business of the Company, and with express authorization from the Company, and shall be delivered to the Company, along with all copies or reproductions of same, upon notification of the termination of the Executive’s employment or at any other time requested by the Company. The Company shall have the right to retain, access, and inspect all property of any kind in the Executive’s office, work area and on the premises of the Company upon termination of the Executive’s employment and at any time during the Executive’s employment, to ensure compliance with the terms of this Agreement.

9.5 Conflicts of Interest. The Executive agrees that during the Term, the Executive will not, without the Company’s prior written consent, engage, either directly or indirectly, in any activity which might reasonably be expected to adversely affect the Company, or any Affiliated Entity (a “Conflict of Interest”) including, but not limited to, (i) ownership of a material interest in any entity with which the Company does business; or (ii) being engaged in any other business activity pursued for gain, profit or other pecuniary advantage if such activity interferes with the Executive’s duties and responsibilities as an employee of the Company, or as an officer of the Company. The foregoing limitations shall not be construed as prohibiting the Executive from making personal investments in such form or manner as will neither require the Executive’s services in the operation or affairs of the companies or enterprises in which such investments are made nor violate the terms of this Agreement. The Executive also agrees that he will not accept any payment, service, loan, gift, trip, entertainment or other favor valued in excess of One Hundred Dollars ($100.00) from an entity with which the Company, or any Affiliated Entity does business and that the Executive will promptly inform an officer of the Company as to each offer received by the Executive to engage in any such activity. The Executive further agrees to disclose to the Company any other facts of which the Executive becomes aware which might reasonably be expected to involve or give rise to a Conflict of Interest or potential Conflict of Interest.

9.6 Non-Solicitation of Employees. The Executive agrees that for the Term, and for a period of one (1) year following termination of the Executive’s employment with the Company for any reason, he will not either directly or indirectly, on his own behalf or on behalf of others: (i) induce or attempt to induce any employee or officer of the Company, or any employee or officer of an Affiliated Entity to terminate such employee’s employment with the Company or service to the Company or any Affiliated Entity; (ii) induce or attempt to induce any consultant or independent contractor to the Company, or any Affiliated Entity to terminate his, her or its consultancy or contractual relationship with the Company, or any Affiliated Entity; and/or (iii) employ or retain, or attempt to employ or retain, any employee of the Company, or any Affiliated Entity.

9.7 Nondisparagement. Following the termination of the Executive’s employment with the Company for any reason, the Executive shall not say, publish or do anything that casts the Company, or any Affiliated Entity, or any officer or director of the Company, or any Affiliated Entity, in an unfavorable light, or disparage or injure the goodwill, business reputation or relationship of the Company, or any Affiliated Entity with existing or potential creditors, counterparties, bankers, analysts, investors, employees or the financial community in general, or the goodwill or business reputation of the employees, directors and/or contractors of the Company, or any Affiliated Entity.

9.8 Acknowledgment of Need for Restrictive Covenants. The Executive acknowledges the necessity of the restrictive covenants set forth herein to protect the Company’s legitimate interests in the Confidential Information, Work Product, business and the goodwill with creditors, counterparties, bankers, analysts, investors, employees and the financial community in general that the Company has established at its substantial investment; and protect the Company as a result of providing the Executive with trade secrets, Confidential Information and other specialized and valuable knowledge, training, and insight regarding the Company’s business and operations. The Executive further agrees and acknowledges that the restrictive covenants are a reasonable limitation as to time, geographic area and scope of activities to be restricted and that such promises do not impose a greater restraint on the Executive than is necessary to protect the goodwill, Confidential Information, Work Product and other legitimate business interests of the Company.

9.9 Reaffirmation of Obligations. Upon termination of his employment with the Company, the Executive, if requested by the Company, shall reaffirm in writing the Executive’s recognition of the importance of maintaining the confidentiality of the Confidential Information, and reaffirm any other obligations set forth in this Agreement that survive the termination of the Executive’s employment with the Company.

9.10 Prior Disclosure. The Executive represents and warrants that he has not used or disclosed any Confidential Information, trade secret, copyright or any other intellectual property he may have obtained from the Company prior to signing this Agreement, in any way inconsistent with the provisions of this Agreement.

9.11 Previously Accessed Confidential Information. The Executive will not, except as the Company may otherwise consent in writing, use any Confidential Information the Executive may have acquired because of employment with the Company prior to execution of this Agreement, whether such information is in the Executive’s memory or embodied in a writing or other physical form.

9.12 Condition of Asset Purchase Agreement. The Executive acknowledges and agrees that it was a condition to the Company’s execution of the Asset Purchase Agreement that the Executive agree to be bound by the covenants contained in this Section 9 and that the agreement by the Executive to be so bound is an integral part of the consideration under the Asset Purchase Agreement.

10. Compliance With Section 409A. This Agreement and the amounts payable and other benefits provided under this Agreement are intended to comply with, or otherwise be exempt from, Section 409A of the Code, after giving effect to the exemptions in Treasury Regulation Section 1.409A-1(b)(3) through (b)(12). This Agreement shall be administered, interpreted and construed in a manner consistent with Section 409A of the Code. If any provision of this Agreement is found not to comply with, or otherwise not be exempt from, the provisions of Section 409A of the Code, it shall be modified and given effect, in the sole discretion of the Compensation Committee and without requiring the Executive’s consent, in such manner as the Compensation Committee determines to be necessary or appropriate to comply with, or to effectuate an exemption from, Section 409A of the Code; provided, however, that in exercising its discretion under this Section 10, the Compensation Committee shall modify this Agreement or any amount payable or other benefits provided under this Agreement, in the least restrictive manner necessary. If this Agreement or any amount payable or other benefit provided under this Agreement shall be deemed not to comply with Section 409A of the Code or any related regulations or other guidance, then neither the Company, any Affiliate, the Compensation Committee or any of their designees or agents shall be liable to the Executive or other person for actions, decisions or determinations made in good faith.

If a payment or benefit obligation under this Agreement arises on account of the Executive’s termination of employment and such payment or benefit obligation constitutes “deferred compensation” (as defined under Treasury Regulation Section 1.409A-1(b)(1), after giving effect to the exemptions in Treasury Regulation Section 1.409A-1(b)(3) through (b)(12)), it shall be payable only after the Executive’s “separation from service” (as defined in Treasury Regulation Section 1.409A-1(h)); provided, however, that if the Executive is a “specified employee” (as defined in Treasury Regulation Section 1.409A-1(i)), any payment that is scheduled to be paid within six (6) months after such “separation from service” shall accrue without interest and shall be paid on the date that is six (6) months after such “separation from service” or, in the case of a payment or benefit obligation payable in installments, on the first day of the seventh month beginning after the date of the Executive’s “separation from service” or, if earlier, within fifteen days after the Executive’s death (and the payment on the first day of the seventh month beginning after the date of the Executive’s “separation from service” shall include any installments that would have been paid during such period after the “separation from service” if the Executive was not a “specified employee.”

With respect to any reimbursement of expenses of, or any provision of in-kind benefits to, the Executive as provided in this Agreement, such reimbursement of expenses or provision of in-kind benefits shall be subject to the following limitations: (i) the expenses eligible for reimbursement or the amount of in-kind benefits provided in one (1) taxable year shall not affect the expenses eligible for reimbursement or the amount of in-kind benefits provided in any other taxable year, except for any medical reimbursement arrangements providing for the reimbursement of expenses referred to in Section 105(b) of the Code; (ii) the reimbursement of an eligible expense shall be made as specified in this Agreement and in no event later than the end of the year in which such expense was incurred and (iii) the right to reimbursement or in-kind benefit shall not be subject to liquidation or exchange for another benefit.

11. Notices. All notices and other communications under this Agreement shall be in writing and shall be given by fax or first class mail, certified or registered with return receipt requested, and shall be deemed to have been duly given three (3) days after mailing or 24 hours after transmission of a fax to the respective persons named below:


If to the Company:		Compensation Committee of the Board of Directors
		c/o CYS Investments, Inc.
		890 Winter Street, Suite 200
		Waltham, Massachusetts 02451
		Phone: (617) 639-0400
		Fax: (617) 507-6439

If to the Executive:		Kevin E. Grant
		to the address of the Executive as most recently listed in the Company’s corporate records
		Phone: (617) 639-0401
		Fax:

A copy of any notice pursuant to this Agreement shall be sent to Hunton & Williams LLP, Riverfront Plaza East, 951 East Byrd Street, Richmond, Virginia 23219 Attention: S. Gregory Cope, Esquire. Either party may change such party’s address for notices by notice duly given pursuant hereto.

12. No Mitigation or Offset. The Executive shall not be required to mitigate the amount of any payment provided for in this Agreement by seeking other employment or otherwise. The Company shall not be entitled to set off against the amounts payable to the Executive under this Agreement any amounts earned by the Executive in other employment after termination of employment with the Company, or any amounts which might have been earned by the Executive in other employment had such other employment been sought.

13. Termination of Prior Agreements. This Agreement terminates and supersedes any and all prior agreements and understandings between the parties with respect to employment or with respect to the compensation of the Executive by the Company; provided, however, that in the event that the Closing contemplated by the Asset Purchase Agreement does not occur, this Agreement shall be terminated, null and void AB INITIO, and any prior agreements and understandings between the parties with respect to employment or with respect to the compensation of the Executive by the Company shall not be terminated, revoked or superseded by this Agreement and such prior agreements and understandings shall remain in full force and effect in accordance with their respective terms.

14. Assignment; Successors. This Agreement is personal in its nature and neither of the parties hereto shall, without the consent of the other, assign or transfer this Agreement or any rights or obligations hereunder; provided that, in the event of the merger, consolidation, transfer, or sale of all or substantially all of the assets of the Company with or to any other individual or entity, this Agreement shall, subject to the provisions hereof, be binding upon and inure to the benefit of such successor and the Company shall ensure that such successor agrees to discharge and perform all the promises, covenants, duties, and obligations of the Company hereunder.

15. Governing Law. This Agreement and the legal relations thus created between the parties hereto shall be governed by and construed under and in accordance with the laws of the Commonwealth of Massachusetts, applicable to agreements made and to be performed entirely therein, without regard to conflict of laws provisions thereof that would apply the law of any other jurisdiction.

16. Entire Agreement; Headings. This Agreement embodies the entire agreement of the parties respecting the matters within its scope and may be modified only in writing. Section headings in this Agreement are included herein for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.

17. Waiver; Modification. Failure to insist upon strict compliance with any of the terms, covenants, or conditions hereof shall not be deemed a waiver of such term, covenant, or condition, nor shall any waiver or relinquishment of, or failure to insist upon strict compliance with, any right or power hereunder at any one or more times be deemed a waiver or relinquishment of such right or power at any other time or times. This Agreement shall not be modified in any respect except by a writing executed by each party hereto.

18. Severability. In the event that a court of competent jurisdiction determines that any portion of this Agreement is in violation of any statute or public policy, only the portions of this Agreement that violate such statute or public policy shall be stricken. All portions of this Agreement that do not violate any statute or public policy shall continue in full force and effect. Further, any court order striking any portion of this Agreement shall modify the stricken terms as narrowly as possible to give as much effect as possible to the intentions of the parties under this Agreement.

Executive’s termination as an officer of the Company, the Company (or any successor thereto) shall provide the Executive with comprehensive coverage under the Company’s officers and directors insurance policy (or policies) on substantially the same terms and levels that it provides to its senior executive officers, at the Company’s sole cost.

20. Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument.

21. Authority of the Company. The Company represents and warrants that it is fully authorized and empowered to enter into this Agreement and that its entering into this Agreement and the performance of its obligations under this Agreement will not violate any agreement between the Company and any other person, firm or organization or any law or governmental regulation.

22. Successor Sections. References herein to sections, rules or regulations of the Act, Code or other applicable law shall be deemed to include any successor sections, rules or regulations.

[REMAINDER OF THE PAGE LEFT INTENTIONALLY BLANK –

SIGNATURE PAGE FOLLOWS]

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly authorized officer, and the Executive has hereunto signed this Agreement, as of the date first above written.


CYS INVESTMENTS, INC.

By:		/s/ Douglas Crocker, II
		Douglas Crocker, II, Chair of the Compensation
		Committee of the Board of Directors

EXECUTIVE

/s/ Kevin E. Grant
Kevin E. Grant

Signature Page to Employment Agreement by and between

CYS Investments, Inc. and Kevin E. Grant

EX-10.2 5 dex102.htm EMPLOYMENT AGREEMENT / FRANCES R. SPARK Employment Agreement / Frances R. Spark

Exhibit 10.2

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on September 1, 2011, and will become effective on September 1, 2011 (the “Effective Date”), by and between Frances R. Spark (the “Executive”) and CYS Investments, Inc., a Maryland corporation (the “Company”).